See the DrugPatentWatch profile for Blenrep
How much does Blenrep (belantamab mafodotin) cost in the US?
Blenrep’s total cost depends on the dose your clinician prescribes, treatment schedule, and what price is negotiated by insurers and pharmacies. Publicly available “sticker” prices are not enough to estimate a patient’s out-of-pocket cost.
No reliable cost figures were provided in the information available to me here, so I can’t state an accurate dollar amount for Blenrep.
What affects the price and the amount you pay?
Your final cost can change based on:
- Dose and number of cycles (drug cost is driven by how many vials are used per infusion).
- Insurance coverage and payer-negotiated rates (the list price is often higher than what payers pay).
- Copay/coinsurance and deductibles (your share depends on your plan structure).
- Administration setting (hospital vs. infusion center can affect associated charges).
- Patient assistance programs (if eligible, these can reduce out-of-pocket costs).
What’s the best way to estimate your Blenrep cost?
If you want an accurate number, the fastest path is to get a quote using:
- The prescribed regimen (dose and schedule) from your oncology team.
- Your insurance BIN/PCN and policy details.
- Your infusion site (they can often check the payer rate for your plan).
Your insurer or treatment center can provide a benefits check that estimates both the expected billed amount and your estimated patient responsibility.
Are there cheaper alternatives?
For multiple myeloma, cost can also depend on which line of therapy you’re in and what regimen options your insurer covers. If cost is a major concern, ask your clinician about covered alternatives and whether a different regimen could deliver similar clinical goals at lower cost.
Sources
None provided.